于一,刘宇扬,史冬梅,赵迎新,周志明,刘晓丽,方哲,贾硕,周玉杰

• 1:首都医科大学附属北京安贞医院心内12病房
• 2:北京市心肺血管疾病研究所

摘要(Abstract)：

<正>冠状动脉造影(coronary artery angiography,CAG)是目前诊断冠心病的金标准。临床上主要根据CAG评估冠状动脉狭窄进而决定治疗方案,选择血运重建[经皮冠状动脉介入治疗(PCI)、冠状动脉旁路移植术(CABG)]或药物治疗。然而,CAG仅能通过形态学评价冠状动脉是否存在狭窄,并不能从功能上明确狭窄血管是否造成供应的心肌缺血。而临床上真正需要血运重建的血管是功能上存在缺血的狭窄

关键词(KeyWords)： 血流储备分数;急性冠状动脉综合征;冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation): 北京市医院管理局临床医学发展专项(ZYLX201303);; 国家临床重点专科建设项目(2013—2014年度)

作者(Author): 于一,刘宇扬,史冬梅,赵迎新,周志明,刘晓丽,方哲,贾硕,周玉杰

参考文献(References)：

• [1]De Bruyne B,Adjedj J.Fractional flow reserve in acute coronary syndromes.Eur Heart J,36:75-76.
• [2]Pijls NH,van Son JA,Kirkeeide R L,et al.Experimental basis of determining maximum coronary,myocardial,and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty.Circulation,1993,87:1354-1367.
• [3]White CW,Wright CB,Doty DB,et al.Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosisN Engl J Med,1984,310:819-824.
• [4]Pijls NH,van Schaardenbrugh P,Manoharan G,et al.Percutaneous coronary intervention of functionally nonsignificant stenosis:5-year follow-up of the DEFER Study.J Am Coll Cardiol,2007,49:2105-2111.
• [5]Pijls NH,Fearon WF,Tonino PA,et al.Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease:2-year followup of the FAME(Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)study.J Am Coll Cardiol,2010,56:177-184.
• [6]De Bruyne B,Pijls NH,Kalesan B,et al.Fractional flow reserveguided PCI versus medical therapy in stable coronary disease.N Engl J Med,2012,367:991-1001.
• [7]Johnson NP,Tóth GG,Lai D,et al.Prognostic value of fractional flow reserve:linking physiologic severity to clinical outcomes.J Am Coll Cardiol,2014,64:1641-1654.
• [8]Potvin JM,Rodés-Cabau J,Bertrand OF,et al.Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris,non-ST-elevation and ST-elevation acute myocardial infarction,or atypical chest pain.Am J Cardiol,2006,98:289-297.
• [9]Fischer JJ,Wang XQ,Sanady H,et al.Outcome of patients with acute coronary syndromes and moderate coronary lesions undergoing deferral of revascularization based on fractional flow reserve assessment.Catheter Cardiovasc Interv,2006,68:544-548.
• [10]Leesar MA,Abdul-Baki T,Akkus NI,et al.Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina.Effect on duration of hospitalization,cost,procedural characteristics,and clinical outcome.J Am Coll Cardiol,2003,41:1115-1121.
• [11]Vilalonga Pereira L,Pereira H,Vinhas H,et al.Long-term follow-up of patients with deferred coronary intervention guided by measurement of fractional flow reserve.Rev Port Cardiol,2013,32:885-891.
• [12]Misaka T,Kunii H,Mizukami H,et al.Long-term clinical outcomes after deferral of percutaneous coronary intervention of intermediate coronary stenoses based on coronary pressure-derived fractional flow reserve.J Cardiol,2011,58:32-37.
• [13]Sels JW,Tonino PA,Siebert U,et al.Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME(Fractional flow reserve versus Angiography for Multivessel Evaluation)study.JACC.Cardiovasc Interv,2011,4:1183-1189.
• [14]Di Serafino L,De Bruyne B,Mangiacapra F,et al.Long-term clinical outcome after fractional flow reserve-versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts.Am Heart J,2013,166:110-118.
• [15]López-Palop R,Carrillo P,Torres F,et al.Results of fractional flow reserve measurement to evaluate nonculprit coronary artery stenoses in patients with acute coronary syndrome.Rev Esp Cardiol(Engl Ed),2012,65:164-170.
• [16]López-Palop R,Carrillo P,Frutos A,et al.Usefulness of the fractional flow reserve derived by intracoronary pressure wire for evaluating angiographically intermediate lesions in acute coronary syndrome.Rev Esp Cardiol,2010,63:686-694.
• [17]Carrick D,Behan M,Foo F,et al.Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction.Am J Cardiol,2013,111:45-50.
• [18]Layland J,Oldroyd KG,Curzen N,et al.Fractional flow reserve vs.angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction:the British Heart Foundation FAMOUS-NSTEMI randomized trial.Eur Heart J,2015,36:100-111.
• [19]Briasoulis A,Palla M,Mostafa A,et al.Fractional flow-guided management in patients with acute coronary syndromes:A systematic review and meta-analysis.Int J Cardiol,2015,187:334-337.
• [20]胡舜英,陈韵岱.ST段抬高心肌梗死抗栓治疗及出血问题.中国介入心脏病学杂志,2013,22:592:598.
• [21]Legalery P,Schiele F,Seronde MF,et al.One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty.Eur Heart J,2005,26:2623-2629.
• [22]Lekston A,Tajstra M,Gsior M,et al.Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.Kardiol Pol,2011,69:336-343.
• [23]Wald DS,Morris JK,Wald NJ,et al.Randomized trial of preventive angioplasty in myocardial infarction.N Engl J Med,2013,369:1115-1123.
• [24]Dellavalle A,De Servi S,Repetto S,et al.Coronary angioplasty in patients with unstable angina:clinical,electrocardiographic and angiographic predictors of in-hospital outcome.R.OS.A.I.Study Group.Ital Heart J,2000,1:555-561.
• [25]No author listed.Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction.Results of the TIMI IIIB Trial.Thrombolysis in Myocardial Ischemia.Circulation,1994,89:1545-1556.
• [26]No author listed.Long-term low-molecular-mass heparin in unstable coronary-artery disease:FRISC II prospective randomised multicentre study.FRagmin and Fast Revascularisation during In Stability in Coronary artery disease.Investigators.Lancet,1999,354:701-707.
• [27]Ntalianis A,Sels JW,Davidavicius G,et al.Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.JACC Cardiovasc Interv,2010,3:1274-1281.
• [28]Primary PCI in Patients with ST-elevation Myocardial Infarction and Multivessel Disease:Treatment of Culprit Lesion Only or Complete Revascularization(PRIMULTI).From Clinical Trials.gov(NCT01960933).https://clinicaltrials.gov/show/NCT01960933.
• [29]Hamm CW,Bassand JP,Agewall S,et al.ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:The Task Force for the management of acute coronary syndromes(ACS)in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC).Eur Heart J,2011,32:2999-3054..
• [30]Steg PG,James SK,Atar D,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Eur Heart J,2012,33:2569-2619
• [31]Toma M,Buller CE,Westerhout CM,et al.Non-culprit coronary artery percutaneous coronary intervention during acute STsegment elevation myocardial infarction:insights from the APEXAMI trial.Eur Heart J,2010,31:1701-1707.
• [32]Kornowski R,Mehran R,Dangas G,et al.Prognostic impact of staged versus"one-time"multivessel percutaneous intervention in acute myocardial infarction:analysis from the HORIZONS-AMI(harmonizing outcomes with revascularization and stents in acute myocardial infarction)trial.J Am Coll Cardiol,2011,58:704-711.
• [33]Aung Naing K,Li L,Su Q,et al.Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.Cochrane Database Syst Rev,2013,6:CD009503.
• [34]Hennigan B,Layland J,Fearon WF,et al.Fractional flow reserve and the index of microvascular resistance in patients with acute coronary syndromes.Euro Intervention,2014,10 Suppl T:T55-T63.